Dabrafenib Impurity 35 | CAS 13036-57-2 - Request Quote
Dabrafenib Impurity 35
| SZ CAT No: | SZ-D120051 |
| CAS No | 13036-57-2 |
| Mol.F. | C5H5ClN2 |
| Mol.Wt. | 128.6 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 2045642-93-9 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabrafenib Impurity 35 is chemically 2-Chloro-4-methylpyrimidine. Dabrafenib Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 13036-57-2
Purchase 13036-57-2
Order 13036-57-2
Enquire 13036-57-2
price of 13036-57-2
13036-57-2 Supplier
13036-57-2 Manufacturer
13036-57-2 Exporter
buy high quality Dabrafenib Impurity 35
Purchase Dabrafenib Impurity 35
Dabrafenib Impurity 35 suppliers
Dabrafenib Impurity 35 manufacturers
Dabrafenib Impurity 35 price
Order Dabrafenib Impurity 35
Enquire Dabrafenib Impurity 35
Dabrafenib Impurity 35 cost
Dabrafenib Impurity 35 Supplier
Dabrafenib Impurity 35 Distributor
Dabrafenib Impurity 35 for Method Validation
Dabrafenib Reference Standard
Dabrafenib Impurity 35 for ANDA Filing
Dabrafenib Impurity 35 for Forced Degradation Studies
Dabrafenib Impurity 35 Identification Standards
Dabrafenib Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


